Vacuum Infusion - The Equipment and Process of Resin Infusion
ATTENTION - Trividia Health · ATTENTION: RISK MANAGEMENT AND ... • Quality Control Program...
Transcript of ATTENTION - Trividia Health · ATTENTION: RISK MANAGEMENT AND ... • Quality Control Program...
QUALITY ASSURANCE AND QUALITY CONTROL REFERENCE GUIDE
FOR MULTI-PATIENT USE FACILITIES
QUALITY ASSURANCE AND QUALITY CONTROL REFERENCE GUIDE
FOR MULTI-PATIENT USE FACILITIESInformation in This Manual is Specific for Healthcare Providers
ATTENTION: RISK MANAGEMENT AND CHIEF MEDICAL OFFICER
ATTENTION:TRUEtest™ Strips contain GDH-PQQ enzyme.
Please carefully review all critical safetyinformation and instructional
materials prior to performing patient blood glucose testing.
www.niprodiagnostics.com
1-800-803-6025 or 1-954-677-4599.
© 2011 Nipro Diagnostics, Inc. TRUE2go, TRUEtest and the Nipro Diagnostics logo are trademarks of Nipro Diagnostics, Inc. F9NPD21 Rev. 22 • F9H01-90
T2g_QA_ManualCVR_F9NPD21r22.indd 1 12/16/11 9:20 AM
QU
ALIT
Y A
SS
UR
AN
CE A
ND
Q
UA
LITY
CO
NT
RO
L REFER
ENC
E GU
IDE
FOR
MU
LTI-P
AT
IENT U
SE FA
CILIT
IES
T2g_QA_ManualCVR_F9NPD21r22.indd 2 12/16/11 9:20 AM
TRUE2go® Quality Assurance / Quality Control Manual
1
IMPORTANT HEALTH AND SAFETY INFORMATIONWARNING!Healthcare Professionals should adhere to Standard Precautions and disinfection procedures when handling or using this device for testing. ALL parts of the TRUE2go Blood Glucose Monitoring System are considered potentially infectious, and capable of transmitting blood-borne pathogens.1,2 Only auto-disabling, single-use lancing devices may be used with this device. For more information on Standard Precautions and practices please refer to http://www.cdc.gov/biosafety/publications/bmbl5.
WARNING!• NEVERreuseTestStrips.NEVERwipeTestStripswithwater,alcohol,or
anycleaner.DO NOTattempttoremovebloodorcontrolsamplefromTestStripsorcleanTestStripsandre-use.ReuseofTestStripswillcauseinaccurateresults.
• NEVERaddaseconddropofsampletoStrip.Addingmoresamplegivesanerrormessage.
CAUTION!Point-of-care blood testing devices such as blood glucose meters should be used only on one patient and not shared. If dedicating blood glucose meters to a single patient is not possible, the meters must be properly cleaned and disinfected after every use following the guidelines found in Meter Care, Cleaning/Disinfection.
We suggest cleaning and disinfecting the Meter after each use to prevent the transmission of blood-borne pathogens. Healthcare Professionals should wear gloves when cleaning and disinfecting the Meter. Wash hands after taking off gloves. Contact with blood presents a potential infection risk. A new pair of gloves should be worn before testing each patient.
We recommend one meter per patient. We suggest to clean and disinfect Meterbetween patients when Meter is used on multiple patients.
Note: Clean to remove blood or soil from the surface of your Meter and disinfect to destroy infectious agents on the surface of Meter after each use.
• TocleananddisinfectMeter,usePDISuperSani-ClothGermicidal Disposablewipes(activeingredients-55%Isopropyl alcohol/Isopropanol,5,000ppm(PartsPerMillion)quarternary ammoniumchlorides)Viraguard/Viraholdwipes(activeingredient- 70%Isopropylalcohol/Isopropanol)ordisinfectantswithidentical activeingredientsfrom www.epa.gov/oppad001/list_d_hepatitisbhiv.pdf. Pleasefollowthepreparedwipesproductlabelmanufacturer’s instructionsforcleaninganddisinfectingtheMeter.• NeverputMeterinliquidsorallowanyliquidstoentertheTest Ports.• LetMeterairdrythoroughlybeforetesting.• Pleasedisposeofwipesaftercleaning/disinfecting.• Washhandsaftertakingoffgloves.• Useanewpairofglovesbeforetestingeachpatient.
Note: For more information on the PDI wipes, visit www.pdipdi.com or for information on Viraguard wipes, visit www.veridien.com.
T2g_QA_ManualTXT_F9NPD21r22.indd 1 12/30/11 10:08 AM
Safety NoticeATTENTION: Pharmacy Staff, Nursing Staff, Laboratory Staff, and Central
Supply Staff – Reminder of Potential for Falsely Elevated Blood Glucose Results due to Drug Interferences
ThisSafetyNoticeisforpersonnelinvolvedintheissuanceofpoint-of-carebloodglucosetestingsystemsandpersonnelinvolvedinactualpoint-of-carebloodglucosetesting.Parenterallyadministereddrugscontainingormetabolizingtomaltoseorgalactose,andorallyadministeredxylosecancausefalselyhighbloodglucoseresultswithcertainpoint-of-carebloodglucosemonitoringsystemsthatutilizetheenzymeglucosedehydrogenase-PQQ(GDH-PQQ)forthemeasuringofabloodglucoseresult.
Please note: The interferences described in this Notice may be seen with all blood glucose monitoring systems that use GDH-PQQ methodology, regardless of the manufacturer of the system.
TheinformationregardingthelimitationsofusingGDH-PQQmethodologymayormaynotbeincludedinthelabelingofdrugscontainingormetabolizingmaltose,galactose,orxylose.Itisimportantthatall staffareawareofthisinterferenceinordertopreventinappropriatetreatmentbasedonfalselyelevatedbloodglucoseresults.Staffmustadviseat-riskpatientswhousebloodglucosemonitoringsystemswithGDH-PQQmethodologyoftheserisksandtheconsequencesofinappropriatetreatment.
Who is at risk?
Patientsatriskforfalselyelevatedbloodglucoseresultsincludethoseusingbloodglucosemonitoringsystemsutilizingglucosedehydrogenase-PQQ,andwhoare:
• Peritonealdialysispatientsreceivingdialysissolutionscontaining icodextrin(e.g.Extraneal®,Icodial®)thatismetabolizedtomaltose;• Receivinginjectionsorinfusionsofsolutionscontaininggalactoseor maltose(includingsomehumanimmunoglobulinpreparations (e.g.Octagam®,WinRho®,SDFLiquid,HepaGamB™);• Patientsundergoingxyloseabsorptiontesting;• Patientsreceivingintravenoussolutionscontainingmaltoseasa substituteforglucoseorasameansforpatienthydration;• Patientsreceivinganydrugs,includinganyinvestigationaldrugsand thosemadebycompoundingpharmacies,whichcontainor metabolizetomaltose,galactose,orxylose(Orencia®,Adept®, Bexxar®).
Note: An At-Risk Patient Identification Notice located under Forms, Section 10, in this Manual may be used for easy identification of at-risk patients.
TRUE2go® Quality Assurance / Quality Control Manual
2
T2g_QA_ManualTXT_F9NPD21r22.indd 2 12/30/11 10:08 AM
Nipro Diagnostics, Inc Blood Glucose Monitoring Systems Using GDH-PQQ • TRUEresult®/TRUEtest™BloodGlucoseTestStrips• TRUE2go®/TRUEtest™BloodGlucoseTestStrips
What causes these interferences?
TheGDH-PQQmethodologydoesnotdistinguishbetweenmaltose,galactose,xylose,andglucosewhenmeasuringbloodglucose.Maltose,galactose,andxylosearenotnormallyfoundintheblood,butcanbefoundwiththeadministrationofcertaindrugs.Whenpresentintheblood,thesesubstancescanfalselyincreasethebloodglucoseresulttoaclinicallysignificantlevel.Afalsehighglucoseresultmayleadtoininappropriatetreatment,suchastheinjectionofinsulin,whichcouldleadtoahypoglycemiccomaanddeath.
Actions required:
• Beawareofthedrugsused(includinganyinvestigationaldrugsand thosemadebycompoundingpharmacies)thatcontainormetabolize maltose,galactose,orxylose,• Atpatientadmission/presentationandperiodicallythroughoutthe patient’sstayatthefacility,assessthepresenceanduseoftherapies containinginterferingdrugs,• Consultwiththepharmacistformoreinformationonwhichdrugshave beenorwillbeadministeredtothepatient,• Identifyandflagfilesorrecordsofat-riskpatients,• Iftherearepre-printorderssetsforpatientsreceivinginterferingdrugs, includeaprescriptiontotestbloodglucoseusinglaboratorymethods,• Useonlylaboratorymethodsformonitoringbloodglucoselevelsin patientsreceivinginterferingdrugs,• Establishfacilityprotocolstoverifypoint-of-care(bedside)blood glucoseresultswithlaboratoryresultsforpatientswhoareunresponsive orunabletocommunicate,• Ensurethatprotocolsfortestingadequatelyaddresstheissuewhenthe patienthistoryisunknown,• Ifyourfacilityprovidesabloodglucosemonitoringsystemforuseat homeforanat-riskpatient,instructthepatientnottouseabloodglucose monitoringsystemthatutilizesGDH-PQQ,includingtheTRUE2goand TRUEresultSystems,• Afterdrugtreatmentiscompleted,ensurethatuseofabloodglucose monitoringsystemthatutilizesGDH-PQQisclearedbytheDoctoror HealthcareProfessionalbeforeuse.
File this Safety Notice for future reference.
Questions?IfyouhaveanyquestionsregardingtheinformationcontainedinthisSafetyNotice,pleasegotowww.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.htm.orcallforassistanceusingthenumberonthefrontcoveroftheManual.
TRUE2go® Quality Assurance / Quality Control Manual
3
T2g_QA_ManualTXT_F9NPD21r22.indd 3 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
4
Introduction
NiproDiagnostics,Inc.isproudtopresenttheTRUE2goBloodGlucoseMonitoringSystem.TheTRUE2goisano-codingsystem,whichmeanstheMeterdoesnothavetobecodedtoeachlotofteststrips.TheQualityAssurance/QualityControlManualisdesignedforusespecificallybytheHealthcareProfessionalforpoint-of-caretestinginamulti-patient,multi-usersetting.HealthcareProfessionalsinyourfacilitynowhaveaverysimpleandaccuratewaytosafelytestbloodglucoselevelsinyourpatients.
NiproDiagnostics,Inc.recognizestheimportanceofpracticingsafeandreliabletestingusingtheTRUE2goBloodGlucoseMonitoringSystem.Therefore,thisManualhasbeendesignedtoprovidethefollowing:
• AbasicunderstandingoftheTRUE2goSystem,• Adetailedtestingguide,• QualityControlProgramrecommendationsfortheTRUE2goSystem inyourfacility,• Acompleteguidetotroubleshootingissuesandconcernsthatmay arisewithusingwiththeTRUE2goSysteminpatientcare,• AcomprehensivecertifiedtrainingprogramforHealthcare ProfessionalsthatwillbeusingtheTRUE2goSystem.
CAUTION!
Please read this entire Manual and all product Instructions for Use before testing. Operators of the TRUE2go Blood Glucose Monitoring System must be trained per the Training Certification Program, Section 8, prior to using the product.
CAUTION!
DO NOT change patient medication, diet, or exercise routine without consulting the patient’s Doctor or Diabetes Healthcare Professional.
Use of TRUE2go in a manner not specified in this Manual is not recommended and may affect the ability to determine true blood glucose levels.
Ourgoalistoprovidequalityhealthcareproductsanddedicatedcustomerservice.ForquestionsabouttheTRUE2goproducts,visitourwebsiteatwww.niprodiagnostics.com.
T2g_QA_ManualTXT_F9NPD21r22.indd 4 12/30/11 10:08 AM
Table of ContentsSafety Notice .........................................................................................................................................1-3Introduction ............................................................................................................................................ 4Table of Contents .................................................................................................................................... 5Section 1: Using TRUE2go in a Clinical Setting
CriticalSafetyInformation/ImportantInformation/Limitations/ExpectedResults.................... 7-9RegulatoryRequirements-CLIA...........................................................................................................10ProficiencyTestingInformation............................................................................................................11MeterSpecifications.................................................................................................................................12MaterialSafetyDataSheets(MSDS)................................................................................................13-18
Section 2: Description of SystemMeter...........................................................................................................................................................20TRUEtestTestStrips..........................................................................................................................20-21TRUEtestGlucoseControlSolution......................................................................................................22Attaching/RemovingTRUE2goMetertoTRUEtestTestStripVial..............................................23
Section 3: Quality Control TestingAutomaticSelf-Test..................................................................................................................................25ControlTest...............................................................................................................................................25HowtoPerformaControlTest........................................................................................................26-27
Section 4: Blood Glucose TestingSampleInformation............................................................................................................................29-30ObtainingaBloodSample.......................................................................................................................30
TipsforFingertipSampling..............................................................................................................30TipsforForearmSampling.........................................................................................................30-31
HowtoPerformaBloodTest...........................................................................................................31-32SystemOutofRangeWarningMessages..............................................................................................32
Section 5: MemoryMemory,ViewingMemory.....................................................................................................................34
Section 6: Care, Cleaning/Disinfection and Storage of SystemSystem(MeterandTestStrips)...............................................................................................................36MeterCare,Cleaning/Disinfection........................................................................................................36TRUEtestTestStrips................................................................................................................................37TRUEtestGlucoseControlSolution......................................................................................................37BatteryReplacement.................................................................................................................................38
Section 7: TroubleshootingTroubleshooting........................................................................................................................................40DisplayMessages......................................................................................................................................41
Section 8: Training Certification ProgramCertificateInformation......................................................................................................................43-44TrainingChecklist..............................................................................................................................45-46TrainingWrittenTest........................................................................................................................47-51TrainingCertificate(example)................................................................................................................52
Section 9: FormsQualityControlLog............................................................................................................................54-55At-RiskPatientIdentificationNotice....................................................................................................56
Section 10: TRUE2go Lifetime WarrantyTRUE2goLifetimeWarranty..................................................................................................................58
Section 11: ReferencesReferences..................................................................................................................................................60
TRUE2go® Quality Assurance / Quality Control Manual
5
T2g_QA_ManualTXT_F9NPD21r22.indd 5 12/30/11 10:08 AM
Section 1:
Using TRUE2go® in a Clinical Setting
T2g_QA_ManualTXT_F9NPD21r22.indd 6 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control ManualCritical Safety Information / Important Information / Limitations / Expected Results
WARNING!TRUEtest Blood Glucose Test Strips utilize glucose dehydrogenase-PQQ (GDH-PQQ). The TRUE2go System MUST NOT be used for the following patient conditions:
• Peritonealdialysispatientsreceivingdialysissolutionscontaining icodextrin (e.g. Extraneal®, Icodial®) that is metabolized to maltose,• Injectionorinfusionofsolutionscontaininggalactoseormaltose, including some human immunoglobulin preparations (e.g. Octagam®, WinRho®, SDF Liquid, HepaGam B™),• Patientsundergoingxyloseabsorptiontesting,• Patientsreceivingintravenoussolutionscontainingmaltoseasa substitute for glucose or as a means for patient hydration,• Anydrugs,includinganyinvestigationaldrugsandthosemadeby compounding pharmacies, which contain or metabolize to maltose, galactose, or xylose (Orencia®, Adept®, Bexxar®).
Using the TRUE2go System for testing patients with the above conditions may result in falsely high glucose results. A falsely elevated glucose result may cause a patient or healthcare professional to take inappropriate steps to bring the blood glucose in normal range, including giving insulin. The inappropriate use of insulin could lead to unconsciousness, severe hypoglycemic coma and possible death. More information may be found in the TRUEtest Test Strip Instructions for Use or at www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.htm3
Limitations• PleasereadallproductInstructionsforUsecarefullybefore referencingorusingthisManual.• UseonlyTRUEtestBloodGlucoseTestStripsandTRUEtestGlucose ControlSolutionwhentestingwiththeTRUE2goMeter.• DonotleaveTestStripswherethestoragetemperatureprintedonvial labelmaybeexceeded(car,trunk,briefcase,etc.).• PerformGlucoseControlTestsbeforeperformingabloodglucose test(SeeQuality Control Testing, Section 3)whenusingtheSystem forthefirsttime.ThreelevelsofTRUEtestGlucoseControlSolution areavailableforQualityControlTesting.Contactyourdistributorto orderdifferentlevelsofGlucoseControlSolution.Werecommend testingatleast2levelsofControl.Fortestingfrequencyandthe numberofControllevelstotest,refertoyourfacilityqualitycontrol procedure/policy.• TRUE2goisanin vitroquantitativesystemthatisusedforself testingandpoint-of-caretestingofhumanwholebloodonly.
7
T2g_QA_ManualTXT_F9NPD21r22.indd 7 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
8
• Themostaccurateresultsareobtainedusingfresh,capillarywhole bloodfromthefingertip.VenouswholeblooddrawninEDTA (purpletoptube)orheparin(greentoptube)maybeusedfortesting. Mixtubecontentsgentlybeforeusing.Usevenousbloodwithin30 minutesafterdrawing.Serum,clottedblood,orplasmacannotbe usedwiththeTRUE2goSystem.• Capillarybloodfromtheforearmmaybeused.Checkwiththe DoctororHealthcareProfessionaltoseeifforearmtestingmaybe usedforglucosetestingonthepatient.Resultsfromtheforearmare notalwaysthesameasresultsfromthefingertip.Usefingertip insteadofforearm:
- Within2hoursofeating,exercise,ortakinginsulin,- Ifthepatient’sbloodglucosemayberisingorfallingrapidlyor
theirresultsoftenfluctuate,- Ifthepatientisillorunderstress,- Iftheglucoseresultmaybeloworhigh,- Ifsymptomsofloworhighglucoselevelsarenotevident.4
• ForevaluationorQualityControlprocedureswhereTRUE2goblood glucosevaluesarecomparedtobloodglucosevaluesgivenbya laboratory,itisrecommendedthatcapillaryorvenouswholeblood obtainedfromthesamesitebeusedforboththelaboratory instrumentaswellastheTRUE2goSystem.Laboratorytestsshould beperformedwithin30minutesofabloodglucosemetertestto minimizethechangesinglucosevaluesduetoglycolysis.Results fromtheTRUE2goSystemareconsideredaccurateifwithin+20% oflaboratoryresults.5Ifpatienthasrecentlyeaten,fingerresults fromtheTRUE2goSystemcanbeupto70mg/dLhigherthan venouslaboratoryresults.6• TheTRUE2goSystemcannotbeusedinthediagnosisofdiabetesor totestbloodglucoseinnewborns.• DONOTperformcapillarybloodglucosetestingoncriticallyill patients.Capillarybloodglucoselevelsincriticallyillpatientswith reducedperipheralbloodflowmaynotreflectthetruephysiological state.Reducedperipheralbloodflowmayresultfromthefollowing conditions(forexample):7• shock• severehypotension• severedehydration• hyperglycemiawithhyperosmolarity,withorwithoutketosis• Testingataltitudesuptoandincluding10,150feetwillnotaffect accurateresults.5• Hematocritlevelsbetween20%and60%willnotaffectaccurate results.5
T2g_QA_ManualTXT_F9NPD21r22.indd 8 12/30/11 10:08 AM
Expected Results
EachpatientshouldhavespecificbloodglucosetargetrangesthataredeterminedbytheDoctororDiabetesHealthcareProfessional.Havingmostbloodglucoseresultswithinthepatient’stargetrangeshowshowwellatreatmentplanisworkingtocontrolglucoselevels. Keepingresultswithinthepatient’stargetrangehelpssloworstopcomplicationsfromdiabetes.
ExpectedResultsforpeoplewithoutdiabetes:8
PlasmaBloodGlucoseResultBeforeeating <110mg/dLTwohoursaftermeals <140mg/dL
• Lowbloodglucose(hypoglycemia)symptomsmayinclude trembling,sweating,intensehunger,nervousness,weaknessor troublespeaking.• Highbloodglucose(hyperglycemia)symptomsmayincludeintense thirst,aneedtourinateoften,adrymouth,vomiting,orheadache.
Ifthepatientisshowinganyofthesesymptoms,checktheirbloodglucose.Ifanyresultseemshigherorlowerthanexpected,repeatthetestwithanewTestStrip.ContacttheDoctororDiabetesHealthcareProfessionalwithanyunusualresults.
TRUE2go® Quality Assurance / Quality Control Manual
9
T2g_QA_ManualTXT_F9NPD21r22.indd 9 12/30/11 10:08 AM
Regulatory Requirements - CLIA
Self-testingandpoint-of-caretestingofbloodglucosehasbeenclassifiedbytheClinicalLaboratoryImprovementAmendments(CLIA)asawaivedtest.CLIArequiresallentitiesthatperformevenonetest,includingwaivedtests,[onmaterialsderivedforthehumanbodyforthepurposeofprovidinginformationforthediagnosis,preventionortreatmentofanydiseaseorimpairmentof,ortheassessmentofthehealthof,humanbeings]tomeetcertainFederalrequirements.Ifanentityperformstestsforthesepurposes,itisconsideredunderCLIAtobealaboratoryandmustregisterwiththeCLIAprogram.
Waivedlaboratoriesmustmeetthefollowingrequirements:
• CompletetheClinicalLaboratoryImprovementAmendmentsof1988 (CLIA)ApplicationforCertification,FormCMS-116.Theformand instructionsoncompletingandmailingtheformarefoundon http://www.cms.hhs.gov/CLIA/06_How_to_Apply_for_a_CLIA_ Certificate_Including_Foreign_Laboratories.asp#TopOfPage.• Payapplicablecertificatefeesbiennially.• Followmanufacturer’stestinstructions,includinginstructionsfor QualityControl,maintenance,andstorageinstructions.
UponapprovalofFormCMS-116,aCertificateofWaiverisforwardedtothelaboratory.
FormoreinformationontheCLIAprogram,seehttp://www.cms.hhs.gov/CLIA/.
Foracomprehensivelookatwaivedtesting,seehttp://www.cdc.gov/mmwr/preview/mmwrhtml/rr5413a1.htm.
TRUE2go® Quality Assurance / Quality Control Manual
10
T2g_QA_ManualTXT_F9NPD21r22.indd 10 12/30/11 10:08 AM
TRUE2go Blood Glucose Monitoring System Proficiency Testing Information
Theobjectiveofproficiencytestingistoqualitativelydeterminetheskilloftheuserofaspecificproductandtheaccuracyoftheresultsobtainedusingtheproduct.Participatinglaboratoriesreceivespecimensfromadistributor,testthespecimensandreporttheresultsbacktothedistributor.Theresultsofallparticipantsaresummarizedinareportthatissenttotheparticipatinglaboratories.Thereportcontainsanevaluationoftheindividuallaboratoryperformanceaswellasacomparisontoasummaryofresultsfromotherparticipatinglabs.
Itisimportanttobeawarethatproficiencysamplesarenotfreshbloodandmaybehavedifferentlyondifferentglucosetestsystems.Theaccuracyoftheresultfromaproficiencysampleisnotanindicatoroftheaccuracyofyoursystemwhentestedwithfreshwholebloodobtainedfromapatient.TheproficiencytestingonlyservestoshowhowyourresultscomparetootherTRUE2gosystemusers.IfyourproficiencysampleresultsarenotwithinacceptablelimitsofotherTRUE2gousers’results,thenyoushouldinvestigatepossiblesourcesoftestingerrorsuchasexpirationdateandstorageconditionsfortheteststrips.Alwaysperformqualitycontroltestingperyourfacility’sproceduresandpoliciestomakesureyoursystemisworkingproperly.TheOwner’sBookletorQAManualwillassistyouwiththisprocess.
TheTRUE2gosystemisoptimizedtogiveaccurateresultswithfresh,capillarywholebloodandvenouswholebloodsamples.VenouswholebloodsamplesmustbetestedimmediatelyorpreservedinavacutainertubecontainingEDTA(purpletop)orheparin(greentop).Thiswillpreservethesampleforapproximately30minutes.RefertotheTRUE2goOwnersBookletandTRUEtestTestStripInstructionsforUseforfurtherinformation.
ResourcestolearnaboutandobtainProficiencySamples:
CollegeofAmericanPathology(CAP)www.cap.org
AmericanAssociationofBioanalystswww.aab.org
TRUE2go® Quality Assurance / Quality Control Manual
11
T2g_QA_ManualTXT_F9NPD21r22.indd 11 12/30/11 10:08 AM
Meter Specifications
Result Range:20-600mg/dL
Sample Size:0.5microliters(0.5µL)
Sample Type: Freshcapillarywholebloodfromthefingerorforearm, venousblooddrawninEDTA(purpletoptube)orheparin (greentoptube)within30minutesofcollection
Test Time: Aslittleas4seconds
Result Value: Plasmacalibrated
Assay Method: Electrochemical
Reference Method: YellowSpringsInstrument(YSI)
Power Supply: One3Vlithiumbattery#CR2032(non-rechargeable) Totalpowerwhenactiveatfullbattery=8.6mW
Battery Life: Approximately1500testsor2years
Automatic Shut-off: After2minutesofnon-use
Weight: 0.6ounces
Size: 1.70”x1.46”x0.89”
Memory Size: 99results
System Operating Range (Meter and Test Strips): RelativeHumidity:10-90%(non-condensing) Temperature:50°-104°F Hematocrit:20-60% Note: Use within specified environmental conditions only.
Chemical Composition: TRUEtest Test Strips: Glucosedehydrogenase-PQQ(Acinetobacter
calcoaceticus),mediators,buffersandstabilizers TRUEtest Glucose Control Solution: Water,d-glucose,buffers,viscosity
enhancingagent,salts,dyeandpreservatives
TRUE2go® Quality Assurance / Quality Control Manual
12
T2g_QA_ManualTXT_F9NPD21r22.indd 12 12/30/11 10:08 AM
Material Safety Data Sheet
Section 1 : Product Information
Product Name : TRUEtest Blood Glucose Test StripsDate Prepared : 16April2008Revision Number :0
Section 2 : Composition / Information on Ingredients
Vial:SilicaGel,polypropylene,polyethyleneTest Strips:Glucosedehydrogenase-PQQ,mediators,buffersandstabilizersTest Strip Box and Package Insert:Paper
Section 3 : Hazard Identification
Nosignificantimmediatehazardsforemergencyresponseareknown.
Section 4 : Emergency First Aid Procedures
Eye: Nofirstaidrequired.Skin: Nofirstaidrequiredforcontactwithskin.Ingestion: Nofirstaidrequiredfromingestion.Inhalation: Nofirstaidrequired.
Section 5 : Fire and Explosion Hazard Data
Flash Point (Method Used): Vial->450°F(estimated),TestStrips-N/A
Flammable Limits: N/A
General Hazard: Solidmaterialmayburnatorabovetheflashpoint.Ifthermallydecomposed,flammable/toxicgasesmaybereleased.Toxicgaseswill formuponcombustion.Hazardouscombustionproductsmayincludeandarenotlimitedto:carbonmonoxide,carbondioxide.
Special Fire Fighting Procedures: Usewaterspraytocoolfireexposedsurfacesandtoprotectpersonnel.Isolate“fuel”supplytofire.Extinguishthefirebycoolingwithwaterspray.Respiratoryandeyeprotectionrequiredforfirefightingpersonnel.
Unusual Fire and Explosion Hazards: Nonedetermined.
TRUE2go® Quality Assurance / Quality Control Manual
13
T2g_QA_ManualTXT_F9NPD21r22.indd 13 12/30/11 10:08 AM
Section 6 : Spill or Leak Procedures
Steps to be taken in case material is released or spilled: Containmaterialtopreventcontaminationofsoil,surfacewaterandgroundwater.Maybeslippinghazard.
Section 7 : Handling and Storage
Storeattemperaturesandconditionsasindicatedontheproductlabel.Storeinoriginalcontainerandkeepvialclosed.
Section 8 : Personal Protection
Ventilation: Usegeneralroomventilation.Respiratory Equipment: NoneProtective Gloves: NoneEye Protection: NoneOther Protective Equipment/Clothing: None
Section 9 : Physical Data Appearance and odor: Vial-Vialwithdesiccantliner,TestStrips-Plasticstripwithreactionarea.
pH: N/ASpecific Gravity: N/ABoiling Point: N/AMelting Point: N/AVapor Pressure: N/AEvaporation Rate: N/ASolubility in Water: N/A
Section 10 : Reactivity Data
Stability: Stableifatstoragetemperatureandoriginalvialclosed.
Conditions to Avoid: Productcanoxidizeanddecomposeatelevatedtemperatures.Avoidputtingwaterinsideofvial,exothermicreactionwilloccur.Temperaturesabove300°Fmaycauseproductdegradationandselfcombustion.
Substances to Avoid: Avoidcontactwithstrongacidsandoxidizingmaterials.
Hazardous Decomposition Products: Flammablehydrocarbons.
Hazardous Polymerization: Willnotoccur.
TRUE2go® Quality Assurance / Quality Control Manual
14
T2g_QA_ManualTXT_F9NPD21r22.indd 14 12/30/11 10:08 AM
Section 11 : Toxicological Information
Chronic Effects of Overexposure: Nonecurrentlyknown.
Carcinogen or Suspected Carcinogen: Noneofthecompoundspresentarelistedasacarcinogenorsuspectedcarcinogen.
Medical Conditions Aggravated by Exposure: Nonecurrentlyknown.
Acute Toxicity Values: Notapplicable.
Section 12 : Ecological Information
Ecologicaleffectsofthisproducthavenotbeendetermined.
Section 13 : Disposal
Primary Container Type: Vialwith50teststrips.
Waste Disposal Method: Eachdisposalfacilitymustdetermineproperdisposalmethodstocomplywithlocal,state,andfederalenvironmentalregulations.
TRUE2go® Quality Assurance / Quality Control Manual
15
T2g_QA_ManualTXT_F9NPD21r22.indd 15 12/30/11 10:08 AM
Material Safety Data Sheet
Section 1 : Product Information
Product Name : TRUEtest Glucose Control Solution - Levels 1, 2, and 3
Date Prepared : 16April2008
Revision Number :0
Section 2 : Composition / Information on Ingredients
Bottle:Polypropylene,polyethyleneControl Solution:Water,d-glucose,buffers,viscosityenhancingagents,salts,dyes,andpreservatives.
Control Solution Box and Package Insert:Paper
Section 3 : Hazard Identification
Nosignificantimmediatehazardsforemergencyresponseareknown.
Section 4 : Emergency First Aid Procedures
Eye: Flushwithcopiousamountsofwater.Skin: Flushwithwater.Ingestion: Contactphysician.Inhalation: Contactphysician.
Section 5 : Fire and Explosion Hazard Data
Flash Point (Method Used): Bottle-N/A,ControlSolution-N/AFlammable Limits: N/AGeneral Hazard: N/ASpecial Fire Fighting Procedures: N/AUnusual Fire and Explosion Hazards: Nonedetermined.
Section 6 : Spill or Leak Procedures
Steps to be taken in case material is released or spilled: Containmaterialtopreventcontaminationofsoil,surfacewaterandgroundwater.Maybeslippinghazard.
TRUE2go® Quality Assurance / Quality Control Manual
16
T2g_QA_ManualTXT_F9NPD21r22.indd 16 12/30/11 10:08 AM
Section 7 : Handling and Storage
Storeattemperaturesandconditionsasindicatedontheproductlabel.Keepbottletightlyclosedwhennotinuse.
Section 8 : Personal Protection
Ventilation: Usegeneralroomventilation.Respiratory Equipment: None.Protective Gloves: NoneEye Protection: NoneOther Protective Equipment/Clothing: None
Section 9 : Physical Data Appearance and odor: Bottle-plasticbottlewithcap,ControlSolution-Redliquid.
pH: N/ASpecific Gravity: N/ABoiling Point: N/AMelting Point: N/AVapor Pressure: N/AEvaporation Rate: N/ASolubility in Water: N/A
Section 10 : Reactivity Data
Stability: Stableatstoragetemperature.Keepbottleclosedwhennotinuse.Conditions to Avoid: N/ASubstances to Avoid: Avoidcontactwithstrongacidsandoxidizingmaterials.Hazardous Decomposition Products: Flammablehydrocarbons.Hazardous Polymerization: Willnotoccur.
Section 11 : Toxicological Information
Chronic Effects of Overexposure: Nonecurrentlyknown.Carcinogen or Suspected Carcinogen: Noneofthecompoundspresentgreaterthan0.1%arelistedasacarcinogenorsuspectedcarcinogen.Medical Conditions Aggravated by Exposure: Nonecurrentlyknown.Acute Toxicity Values: Notapplicable.
TRUE2go® Quality Assurance / Quality Control Manual
17
T2g_QA_ManualTXT_F9NPD21r22.indd 17 12/30/11 10:08 AM
Section 12 : Ecological Information
Ecologicaleffectsofthisproducthavenotbeendetermined.
Section 13 : Disposal
Primary Container Type: Bottlewith3mLGlucoseControlSolution.
Waste Disposal Method: Eachdisposalfacilitymustdetermineproperdisposalmethodstocomplywithlocal,state,andfederalenvironmentalregulations.
TRUE2go® Quality Assurance / Quality Control Manual
18
T2g_QA_ManualTXT_F9NPD21r22.indd 18 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
20
Top
Description of System
Meter
1.Set Button- Markresultasanalternatesite,turnMeteron/offforMemory,view/scrollresultsinMemory.Note: Use of Memory function is not recommended in a multi-patient setting.
2.Display Screen-Showsresults,messages,userprompts,information3.Drop Symbol4.Units of Measure (Note: Factory set, cannot be changed by user.)5.Strip Release Button-ReleasesTestStripaftertestingiscomplete.6.Test Port- PlacetoinsertTRUEtestTestStrip7.Battery Door- Opentoreplacebattery.Useonenon-rechargeable
3Vlithiumbattery(#CR2032),positive(“+”)sideup(See BatteryReplacement,Section6, for more details).
8.Meter Label- ContainsSerialNumberoftheMeterandphonenumbertocallforassistance.
Test Strip
9.Contact End-InsertintoTestPortwithTRUEtestnamefacingup.10.Sample Tip- Bringsample(fresh,capillaryorvenousbloodorGlucose
ControlSolution)toedgeofTip.Capillaryactiondraws sampleintoTestStripfortesting.
Full Display Bottom
1
2
2
3
45
6
7
8
910
T2g_QA_ManualTXT_F9NPD21r22.indd 20 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
21
Sample Placement
CorrectPlacement IncorrectPlacement
• Allowsample(bloodorControl)tobedrawnintoSampleTip.
CAUTION! Holding the Test Strip to blood sample too long after the Meter begins testing may cause inaccurate results.
• DonotsmearorscrapesamplewithTipofTestStrip.• DonotapplymoresampletotheTestStripafterremovingtheTest Stripfromthesampledrop• DonotapplybloodorControltotopofTestStrip.• DonotinsertSampleTipintotheMeter.
Note: Inserting the Test Strip backwards (Sample Tip into Test Port) after sampling may cause the Meter not to turn on. If Meter does not turn on, see Troubleshooting,Section8.
Test Strip Vial Label
1.Lot Number (LOT)- UsedforidentificationoflotforQCForm, usedasareferenceifcallingforassistance.
2.Expiration Dates (EXP)- TheprintedExpirationDateislocatedontheTestStripvialnexttoEXP.Writethedatefirstopenedonviallabel.DiscardvialandunusedTestStripsifeitherdateprintedafterEXP onTestStripviallabelor4monthsafterdatewrittenonviallabelhaspassed.
3.GDH - PQQ- Enzymeusedforglucosetestingisglucosedehydrogenase-PQQ.SeeCritical Safety Information / Important Information / Limitations / Expected Results, Section 1forlimitationsofusewithpatient.
CAUTION! Use of Test Strips or Glucose Control Solution past the Expiration Dates may give incorrect test results. Discard out-of date products and test with new products.
4.Control Range- RangeofnumbersinwhichControlTestresultmustfall toassuretheSystemisworkingproperly.
12
3 4
3
T2g_QA_ManualTXT_F9NPD21r22.indd 21 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
22
Glucose Control Solution Bottle Label
1.Lot Number (LOT)- UsedforidentificationoflotforQCForm,usedasa referenceifcallingforassistance.
2.Expiration Dates (EXP)- TheprintedExpirationDateislocatedontheControlbottlelabelnexttoEXP.Writethedatefirstopenedonbottlelabel.DiscardbottleandunusedControlSolutionifeitherdateprintedafterEXP onControlbottlelabelor3monthsafterdatewrittenonbottlelabelhaspassed.
3.Control Level-ThreelevelsofTRUEtestGlucoseControlSolutionare available,Levels1,2,and3.Werecommendtestingat least2levelsofControl.Fortestingfrequencyandthe numberofControllevelstested,refertoyourfacility qualitycontrolprocedure/policytotest.
1
2
3
T2g_QA_ManualTXT_F9NPD21r22.indd 22 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
23
Attach / Remove TRUE2go Meter to TRUEtest Test Strip Vial
TheTRUE2goMeterisdesignedtoattachtothetopoftheTRUEtestTestStripvialforeaseofuse.
Attach
1. PlaceTestStripvialuprightonflatsurfacewithvialcaplipfacingfront.2. WithMeterTestPortfacingtotheright,placebottomoftheMeterfirmlyon
thevialtop.Metermustbeseatedflatonthetopofthevialcap.3. Holdingthevial,twisttheMeter¼turnclockwise.ThesectionoftheMeter
wheretheTestPortislocatedshouldcovertheviallipifattachedproperly.
4. Toopenthevial,liftupontheMeterundertheTestPort.5. Toclosethevial,pressfirmlyontheareaonthetopoftheTestPort.
Remove
1. Holdingthevial,twisttheMeter¼turncounterclockwise.2. LiftoffMeterfromvialtop.
Note: The Meter may be used for testing without attaching to the vial.
LiftUpToOpen
PressDownToClose
TestPort
VialLip
T2g_QA_ManualTXT_F9NPD21r22.indd 23 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
25
Quality Control Testing
QualityControlproceduresareusedtodetecterrorsthatmayoccurduetotestsystemerrors,productdefects,adverseenvironmentalconditionsandvarianceinoperatorperformance.OngoingQCproceduresarealsousedtodetectanyperformanceissuesoftheSystemovertime.FacilityQualityControlTestingPolicyandProcedureshouldadheretothemanufacturer’sinstructionsforuseandregulatoryguidelinessetforthbyappropriatestate,regionalornationallicensingoraccreditingagencies.TRUE2goisano-codingsystem,whichmeanstheMeterdoesnothavetobecodedtoeachlotofTestStrips.Toassureaccurateandreliableresults,TRUE2goofferstwokindsofQualityControlTests.ThesetestsensurethatTRUE2goisworkingproperlyandtestingtechniqueisgood.
Automatic Self Test
Anautomaticself-testisperformedbytheMetereachtimeaTRUEtestTestStripisinsertedcorrectlyintotheTestPort.AfterinsertingtheStripintotheTestPort,ifthefullDisplay(showingnomissingsegments,seeDescriptionofSystem,Section2)followedbytheDropSymbolappears,theMeterisworkingproperly.Ifanerrormessage(E-1,E-2etc.)appearsintheDisplayafterinsertingaTestStrip,theMeterwillnotperformaglucosetest.SeeDisplayMessages,Section8formoreinformationonerrormessages.
CAUTION! If any segments are missing in the Display when the Test Strip is inserted into the Test Port, do not use the Meter for testing. Call for assistance using the phone number on the QA/QC Manual cover.
Control Test
UseONLYTRUEtestGlucoseControlSolutiontochecktheperformanceoftheSystem.ItisimportanttoperformControlTestswithmorethanonelevelofControltoassurethattheSystemisworkingproperlyandtestingtechniqueisgood.ThreelevelsofTRUEtestGlucoseControlSolution(Levels1-3)containingknownamountsofglucoseareavailable.CallthephonenumberontheQA/QCManualcoverorcontactyoursuppliertoorderdifferentlevelsofControlSolution.ControlTest(s)shouldbeperformed:
• BeforeusingtheSystemforthefirsttime,• Forpracticetoensurethattestingtechniqueisgood,• WhenopeninganewvialofStrips,• Ifresultsseemunusuallyhighorlowbasedonthepatient’scondition,• IfStripvialhasbeenleftopenorexposedtoextremeheat, coldorhumidity,• WheneveracheckontheperformanceoftheSystemisneeded,or• IfMeterdamageissuspected(Meterdropped,crushed,wet,etc.).
CAUTION! Glucose Control ranges printed on the Test Strip vial are ranges for Control Tests results only. These ranges are not to be used by patients for blood glucose management. Contact a Doctor or Diabetes Healthcare Professional for individualized blood glucose target ranges. DO NOT consume Glucose Control.
DropSymbol
FullDisplay
T2g_QA_ManualTXT_F9NPD21r22.indd 25 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
26
How to Perform a Control Test
UsetheQualityControlLoglocatedinForms, Section 9torecordControlTestresults.
1. AllowControlbottle,vialofTestStripsandMetertoadjusttoroomtemperature(59°-86°F).
Note: Performing a Control Test at temperatures above or below room temperature may cause the Control to read as a blood test.
2. CheckdatesonControlbottlelabelandTestStripviallabel.• DonotuseControlif3monthspastwrittenopeneddateor afterEXP dateprintedonControlbottlelabel.• DonotuseTestStrips4monthspastwrittenopeneddateor afterEXP dateprintedonTestStripviallabel.
Discardoutofdateproductsandusenewproductsifeitherdatehaspassed.
3. SwirlorinvertControlbottlegentlytomixControl.DO NOT SHAKE!
4. OpenTestStripvialbypushingupundertheTestPortoftheMeterattachedtothevial.RemoveoneTestStrip.ClosevialimmediatelybyfirmlypressingdownonthetopoftheTestPortarea.
Note: Use Test Strip quickly after removal from vial. Test Strips that have been left outside the vial too long will give an error message. If an error message appears in the Display, release and discard the old Test Strip and test with a new Test Strip.
5. WithMeteroff,inserttheTestStripContactEnd(TRUEtestnamefacingup)intotheTestPort.Meterturnson.KeeptheTestStripintheMeteruntiltestingiscomplete.
6. WaituntiltheDrop SymbolappearsintheDisplay.
Note: If Test Strip is removed before testing is finished, an error message appears. Release and discard old Test Strip. Test with new Test Strip.
7. RemovecapfromControlbottle.TurnControlbottleupsidedown.SqueezeonedropofControlontoacleantissue.Wipeoffbottletip.
8. GentlysqueezeanotherdropofControlontoasmallpieceofunusedaluminumfoil,clearplasticwrap,oraclean,nonporoussurface.(Discardfoil/wraporcleanareaafteruse.)
LB0010
9 JUNE 2009
LiftUpToOpen
PressDownToClose
DropSymbol
T2g_QA_ManualTXT_F9NPD21r22.indd 26 12/30/11 10:08 AM
9. WhileTestStripisstillintheMeter,touchedgeofTestStripSampleTiptodropofControlandallowdroptobedrawnintoTestStrip.RemoveTestStripfromthedropwhendashesappearacrosstheMeterDisplay.Meteristesting.
Note: If Meter does not begin testing soon after drawing up sample (dashes appear in the Display), release and discard Test Strip. Repeat the test with a new Test Strip. If problem persists, See Troubleshooting,Section7.
10.ControlTestresultisdisplayed.ComparetheMeterresulttotheControlRangeprintedontheTestStripviallabelfortheControllevelthatisbeingtested.Iftheresultisinrange,theSystemcanbeusedfortestingblood.Iftheresultisnotwithinrange,repeatthetestusinganewTestStrip.
Note: Performing a Control Test at temperatures above or below room temperature (59° - 86°F) may cause the Control to read as a blood test.
CAUTION! If Control Test is outside of the correct range, perform test again using a new Test Strip and a new drop of Control. If the result is still outside the correct range, the System should not be used for testing blood. Call for assistance (see front cover for phone number).
11.RecordtheresultintheTRUE2goQualityControlLog(seeForms, Section9).
12.HoldtheTestStripvialwithTestStrippointingdown.PresstheStripReleaseButtontoreleaseanddiscardtheTestStripintoanappropriatecontainer.TheMeterturnsoff.
TRUE2go® Quality Assurance / Quality Control Manual
27
T2g_QA_ManualTXT_F9NPD21r22.indd 27 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
29
Blood Glucose Testing
Sample Information
Fresh,capillarywholebloodfromthefingerorforearmistherecommendedsampletobeusedfortestingbloodglucose.AlwayscheckwiththeDoctororDiabetesHealthcareProfessionalbeforeusingasamplefromtheforearm.Resultsfromtheforearmarenotalwaysthesameasresultsfromthefingertip.Usefingertipinsteadofforearm:
- Within2hoursofeating,exercise,ortakinginsulin,- Ifthepatient’sbloodglucosemayberisingorfallingrapidlyortheir
resultsoftenfluctuate,- Ifthepatientisillorunderstress,- Iftheglucoseresultmaybeloworhigh,- Ifsymptomsofloworhighglucoselevelsmaynotbeevident.4
Note: Venous whole blood drawn in EDTA (purple top tube) or heparin (green top tube) may be used for testing. Use venous blood within 30 minutes of collecting for best results. Mix tube contents gently before using. Serum, clotted blood, and plasma cannot be used with the TRUE2go System.
ForevaluationwhereTRUE2gobloodglucoseresultsarecomparedtobloodglucoseresultsgivenbyalaboratoryinstrument,itisrecommendedthatcapillaryorvenouswholebloodobtainedfromthesamesamplingsitebeusedforboththelaboratoryinstrumentaswellastheTRUE2goSystem.Laboratorytestsshouldbeperformedwithin30minutesofabloodglucosemetertesttominimizethechangesinglucosevaluesduetoglycolysis.ResultsfromtheTRUE2goSystemareconsideredaccurateifwithin+20%oflaboratoryresults.5Ifpatienthasrecentlyeaten,fingerresultsfromtheTRUE2goSystemcanbeupto70mg/dLhigherthanvenouslaboratoryresults.5
TheTRUE2goSystemcannotbeusedonnewborns.PerformlaboratoryglucoseTestsoncriticallyillpatients.
WARNING!TRUEtest Blood Glucose Test Strips utilize glucose dehydrogenase-PQQ (GDH-PQQ). The TRUE2go System MUST NOT be used for the following patient conditions:
• Peritonealdialysispatientsreceivingdialysissolutionscontaining icodextrin (e.g. Extraneal®, Icodial®) that is metabolized to maltose,• Injectionorinfusionofsolutionscontaininggalactoseormaltose, including some human immunoglobulin preparations. (e.g. Octagam®, WinRho®, SDF Liquid, HepaGam B™),• Patientsundergoingxyloseabsorptiontesting,• Patientsreceivingintravenoussolutionscontainingmaltoseasa substitute for glucose or as a means for patient hydration,
T2g_QA_ManualTXT_F9NPD21r22.indd 29 12/30/11 10:08 AM
• Anydrugs,includinganyinvestigationaldrugsandthosemadeby compounding pharmacies, which contain or metabolize to maltose, galactose, or xylose (Orencia®, Adept®, Bexxar®).
Using the TRUE2go System for testing patients with the above situations may result in falsely high glucose results. A falsely elevated glucose result may cause a patient or healthcare professional to take appropriate steps to bring the blood glucose in normal range, including giving insulin. The inappropriate use of insulin could lead to unconsciousness, severe hypoglycemic coma and possible death. More information may be found in the TRUEtest Test Strip Instructions for Use or at www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.htm.3
Obtaining a Blood Sample for Blood Glucose Testing
Refertoyourfacilityapprovedmethodforlancingtoobtainabloodsampleforbloodglucosetesting.FollowOSHAprecautionsforblood-bornepathogens.
CAUTION! We suggest cleaning and disinfecting the meter after each use to prevent the transmission blood-borne pathogens. Only auto-disabling, single-use lancing devices may be used with this device.
Tips for Fingertip Sampling
Note: A new pair of gloves should be worn before obtaining a blood sample. Contact with blood presents an infection risk.
1. Selectfingertip.Cleanareawithsoapandwarmwater,rinseoruseanapproveddisinfectanttocleanthearea.Drythoroughly.
2. Lancefingertip.3. Tohelpblooddropform,lowerthehandtoalevelbelowtheheartand
gentlymassagethefingerfrompalmtofingertip.AllowtheblooddroptoformbeforeattemptingtoapplytheTestStrip.
4. Discardallbiohazardmaterialsintoappropriatecontainer.Washhandsaftertakingoffgloves.
Tips for Forearm Sampling
• CheckwithyourDoctororDiabetesHealthcareProfessionaltosee if forearm testing is appropriate for the patient.
• Resultsfromtheforearmarenotalwaysthesameasresultsfrom the finger.
• Use finger for testing instead of forearm for more accurate results;- Within 2 hours of eating, exercise, or taking insulin,- If the patient’s blood glucose may be rising or falling rapidly or their
results often fluctuate,- If the patient is ill or under stress,- If the glucose result may be low or high,- If symptoms of low or high glucose levels are not evident.4
TRUE2go® Quality Assurance / Quality Control Manual
30
T2g_QA_ManualTXT_F9NPD21r22.indd 30 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
31
Note: A new pair of gloves should be worn before obtaining a blood sample. Contact with blood presents an infection risk.
1. Selectarea.Cleantheareawithsoapandwarmwater,rinseoruseanapproveddisinfectant.Drythoroughly.
2. Rubareavigorouslyorapplyawarm,drycompresstoincreasebloodflow.
3. Lanceforearm.
4. Discardallbiohazardmaterialsintoappropriatecontainer.Washhandsaftertakingoffgloves.
How to Perform a Blood Glucose Test
1. CheckdatesonTestStripviallabel.• DonotuseTestStrips4monthspastwrittenopeneddateor afterEXP dateprintedonTestStripviallabel.
2. Cleantheareatobelancedwithanapproveddisinfectant.Drythoroughly.
3. RemoveoneTestStripfromTestStripvialbypressingupundertheTestPortoftheMeterattachedtotheTestStripvial.CloseTestStripvialimmediatelybypressingfirmlydownonthetopoftheTestPortarea.
Note: The TRUE2go is a no-coding system, which means the Meter does not have to be coded to each lot of test strips.
Note: Use Test Strips quickly after removal from Test Strip vial. Test Strips that have been left out of the vial too long will give an error message. If error message displays, release and discard the old Test Strip and test with a new Test Strip.
4. WithMeteroff,inserttheTestStripContactEnd(TRUEtestnamefacingup)intotheTestPort.TheMeterturnson.KeeptheTestStripintheMeteruntilthetestiscomplete.
Note: Removing the Test Strip before the result is displayed cancels the test. An error message appears. Retest with a new Test Strip and do not remove the Test Strip from the Meter before the result is displayed.
5. WaituntiltheDrop SymbolappearsintheDisplay.
Note: To mark the test as an alternate site, press the Set Button.
6. Obtainthebloodsample.Allowblooddroptoform(seeObtainingaBloodSample,Section4).
LiftUpToOpen
PressDownToClose
DropSymbol
T2g_QA_ManualTXT_F9NPD21r22.indd 31 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
32
7. WithTestStripstillinMeter,touchedgeofSampleTiptoblooddropandallowbloodtobedrawnintoStrip.RemoveTestStripSampleTipfromsampledropimmediatelyafterdashesappearacrosstheMeterDisplay.
CAUTION! Holding the Test Strip to blood sample too long after the Meter begins testing may cause inaccurate results.
Note: If Meter does not show dashes in the Display soon after touching the sample to the Sample Tip, release and discard the Test Strip. Repeat the test with a new Test Strip and a new sample. If problem persists, see Troubleshooting,Section7.
8. Afterthetestisfinished,thebloodglucoseresultisdisplayed.
9. HoldtheTestStripvialwiththeTestStrippointingdown.PresstheStripReleaseButtontoreleaseanddiscardtheTestStripintotheappropriatecontainer.TheMeterturnsoff.
10.Recordtheresultasrequiredbyyourfacility.
System Out of Range Warning Messages
WARNING!
TheTRUE2goSystemaccuratelyreadsbloodglucoselevelsfrom20-600mg/dL.
Iftestresultislessthan20mg/dL,“Lo”appearsintheMeterDisplay.
Ifthetestresultisgreaterthan600mg/dL,“HI”appearsintheMeterDisplay.
ALWAYSrepeatthetesttoconfirmlow(“Lo”)orhigh(“HI”)results.Ifresultsstilldisplay“Lo”or“HI”,contacttheDoctororDiabetesHealthcareProfessionalimmediately.
T2g_QA_ManualTXT_F9NPD21r22.indd 32 12/30/11 10:08 AM
Memory
Note: Use of the Memory feature may not be suitable for multi-patient use of the System. Check with the facility procedure/policy before use.
TheTRUE2goMeter’sMemoryholds99results.
TheoldestglucoseresultisremovedfromtheMemorywhentheMemoryisfullandanewglucoseresultisadded.
Viewing Memory
1. PresstheSetButtonforafewsecondsandrelease.TheMeterturnsonandthemostrecentresultinMemoryisdisplayed.
2. PresstheSetButtonandreleasetoadvancetothenextresultinMemory.ContinuetopressandreleasetheSetButtontoscrollthroughtheresults.HoldingtheSetButtonscrollsthroughtheresultsquickly.
Bloodtestresultsbeginas“R1”followedbytheglucoseresult.“R2”followswiththenextglucoseresult,andsoon.(R3,result;R4,result;…).
Controltestresultsbeginas“C1”followedbytheControlTestresult.“C2”followswiththenextControlTestresult,andsoon.(C3,result;C4,result;…).
Alternatesitebloodtestresultsbeginas“A1”followedbytheglucoseresult.“A2”followswiththenextglucoseresult,andsoon.(A3,result;A4,result;…).
TRUE2go® Quality Assurance / Quality Control Manual
34
BloodTestResult
ControlTestResult
AlternateSiteBloodTestResult
T2g_QA_ManualTXT_F9NPD21r22.indd 34 12/30/11 10:08 AM
Section 6:
Care, Cleaning/Disinfection and Storage of System
T2g_QA_ManualTXT_F9NPD21r22.indd 35 12/30/11 10:08 AM
CAUTION!Point-of-care blood testing devices such as blood glucose meters should be used only on one patient and not shared. If dedicating blood glucose meters to a single patient is not possible, the meters must be properly cleaned and disinfected after every use following the guidelines found in Meter Care, Cleaning/Disinfection.
CAUTION!Healthcare Professionals should wear gloves when cleaning anddisinfecting the Meter. Wash hands after taking off gloves as contactwith blood presents a risk of infection.
We recommend one meter per patient. We suggest cleaning and disinfection of Meter between patients when Meter is used on multiple patients.
Caring for the TRUE2go System
• StoretheSystem(Meter,TestStrips,GlucoseControlSolution)inan areaprotectedfromliquids,dustanddirt.• StoretheSysteminadryplaceatroomtemperature,36°-86°F. DO NOT REFRIGERATE OR FREEZE.
Meter Care, Cleaning/Disinfection
Note: Clean to remove blood or soil from the surface of your Meter and disinfect to destroy infectious agents on the surface of Meter after each use.
Remove meter from vial before cleaning to prevent deterioration of vial label.
• TocleananddisinfectMeter,usePDISuperSani-ClothGermicidal Disposablewipes(activeingredients-55%Isopropyl alcohol/Isopropanol,5,000ppm(PartsPerMillion)quarternary ammoniumchlorides)Viraguard/Viraholdwipes(activeingredient- 70%Isopropylalcohol/Isopropanol)ordisinfectantswithidentical activeingredientsfromwww.epa.gov/oppad001/list_d_hepatitisbhiv.pdf. Pleasefollowthepreparedwipesproductlabelmanufacturer’s instructionsforcleaninganddisinfectingtheMeter.• NeverputMeterinLiquidsorallowanyliquidstoentertheTestPorts.• LetMeterairdrythoroughlybeforetesting.• Pleasedisposeofwipesaftercleaning/disinfection.• Washhandsaftertakingoffgloves.• Useanewpairofglovesbeforetestingeachpatient.
Note: Prepared Isopropyl Alcohol (70%) wipes are commercially available from a variety of manufacturers. For more details on cleaning, contact our Customer Care using the phone number on the cover of the QA/QC Manual. For more information on the PDI Super Sani-Cloth wipes, visit www.pdipdi.com or for information on Viraguard wipes, visit www.veridien.com.
TRUE2go® Quality Assurance / Quality Control Manual
36
T2g_QA_ManualTXT_F9NPD21r22.indd 36 12/30/11 10:08 AM
TRUEtest Test Strips
• StoreTestStripsinoriginalvialonly.DonottransferoldTestStrips intonewvialorstoreTestStripsoutsideofvial.• WritethedatefirstopenedonTestStripviallabel.Discardvialand unusedTestStripsifeitherEXP dateprintedonTestStripviallabel or4monthsafterdatewrittenonviallabelhaspassed.• CloseTestStripvialimmediatelyafterremovingoneTestStrip.Store inadryplaceatroomtemperaturebelow86°F. DO NOT REFRIGERATE OR FREEZE.• DonotreuseTestStrips.• Donotbend,cutoralterTestStripsinanyway.
TRUEtest Glucose Control Solution
• WritethedatefirstopenedonControlbottlelabel.Discardbottleif eitherEXP dateprintedonbottlelabelor3monthsafterdatewritten onbottlelabelhaspassed.• Afteruse,wipebottletipcleanandrecaptightly.• Storeatroomtemperature,36°-86°F. DO NOT REFRIGERATE OR FREEZE.
TRUE2go® Quality Assurance / Quality Control Manual
37
T2g_QA_ManualTXT_F9NPD21r22.indd 37 12/30/11 10:08 AM
(Continued from previous page.)
Battery Replacement
If“Lb”or“db”appearsintheDisplay,changethebattery.Useonlyanew3Vnon-rechargeablelithiumbattery(#CR2032).
1. RemoveMeterfromvial(seeAttach/RemoveTRUE2goMetertoTRUEtestTestStripVial,Section2).
2. TurnMeterovertoseetheMeterlabelandBatteryCover.
3. PlacetheedgeofacoinintotheslotlocatedinthecenteroftheBatteryCover.TwistcoinslightlycounterclockwiseuntilBatteryCoverisloose.Removecoinfromslot.
4. HoldingtheMeteroveryourotherhand,turntheMeteroversotheMeterDisplayfacesup.TheBatteryCoverandbatterydropout.
5. TurnMeterbackover.Replacebatterywithanew3Vnon-rechargeablelithiumbattery(#CR2032),positive(“+”)sidefacingup.
6. ReplaceBatteryCover,withslotfacingupandmetaltipsinslots.FirmlypushBatteryCoverdownusingtheedgeofthecoinandturnthecoinslightlyclockwisetoclose.
7. Discardtheoldbatteryinanappropriatecontainer.
8. PresstheSetButtontoturntheMeteron.IfMeterwillnotturnon,checkthatthebatterywasinstalledproperlywith“+”facingup.Ifnot,removeandreinsertbatteryandtryagain.Callforassistanceifproblempersists.
9. OnceMeterturnson,re-attachMetertovial(seeAttach/RemoveTRUE2goMetertoTRUEtestTestStripVial,Section2).
Caution! Batteries may explode if mishandled or incorrectly replaced. Do not dispose of battery in fire. Do not take apart or attempt to recharge battery. Dispose according to local/country regulations.
TRUE2go® Quality Assurance / Quality Control Manual
38
Slot
T2g_QA_ManualTXT_F9NPD21r22.indd 38 12/30/11 10:08 AM
Troubleshooting
ThefollowingisabriefguideforTroubleshootingthemostcommonerrorswhenusingTRUE2go.IfanyproblemsarisethatcannotberesolvedbyusingthisguideortheDisplayMessages,pleasecallforassistance.
1) After inserting Test Strip into Test Port, Meter does not turn on.
TestStripisinsertedupsidedownorbackwards.
- Remove Test Strip. Re-insert Test Strip correctly.
Stripnotfullyinserted.
-Remove Test Strip. Re-insert Test Strip fully into Meter.
Striperror.
-Remove Test Strip. Repeat with new Test Strip.
Deadornobattery.
-Replace battery.
Batteryinbackwards.
-Check placement of battery. Battery positive (“+”) side must face up.
Metererror.
-Call for assistance.
2) After applying the sample to the Test Strip, test does not start / Meter does not begin testing.
Sampletoosmall.
-Repeat test with a new Test Strip and a larger sample drop.
Sampleappliedaftertwominuteautomaticshut-offofMeter.
-Repeat test with a new Test Strip and apply sample within 2 minutes.
ProblemwithTestStrip.
-Repeat test with a new Test Strip.
ProblemwithMeter.
-Call for assistance.
TRUE2go® Quality Assurance / Quality Control Manual
40
T2g_QA_ManualTXT_F9NPD21r22.indd 40 12/30/11 10:08 AM
Display Messages
Display Reason Action
Temperature ErrorToo cold or too hot for testing.
MoveSystemtoareabetween50°-104°Fandwait30minutesforSystemtoreachroomtemperaturebeforetesting.
Sample not detected or using wrong Test Strip
RetestwithanewTRUEtestTestStripandalargersample.
Used Test Strip, Test Strip outside of vial too long, sample on top of Test Strip
RepeatwithanewTestStrip.MakesuresampleistouchedtoedgeofSampleTip.Iferrorpersists,callforassistance.
Meter error Callforassistance.
Test Strip error RetestwithanewTestStrip.Iferrorpersists,callforassistance.
Test Strip removed during test
RetestwithanewTestStrip.MakesureresultisdisplayedbeforeremovingTestStrip.
Meter Error ResultwasnotrecordedinMemory.Retestwithanewstrip.Iferrorpersists,callforassistance.
Low Battery About50testscanbeperformedbeforebatterydies.Replacebattery.
Dead battery Replacebattery.
Out of range high results > 600 mg/dL
WARNING!
RetestwithanewTestStrip.Ifresultisstill“HI”or“Lo”,contactDoctorimmediately.
WARNING!
Out of range low results < 20 mg/dL
If error message still appears after action, any other error messages appear that are not shown above, or troubleshooting does not solve the problem, call for assistance.
TRUE2go® Quality Assurance / Quality Control Manual
41
T2g_QA_ManualTXT_F9NPD21r22.indd 41 12/30/11 10:08 AM
TRUE2go Blood Glucose System Training Certification Program
Trainedandcompetenttestingpersonnelareessentialtogoodqualitytestingandpatientcare.Waivedtestingsitesaresubjecttoahighrateofpersonnelturnover.Personnelshouldbetrainedandcompetentineachtesttheywillperformbeforereportingpatientresults.Inaddition,trainingshouldincludeaspectsofsafety(includingInfectionControlPolicies)andQualityControl.TheRiskManagementandChiefMedicalOfficer,andotherpersonsresponsibleforoverseeingtestingshouldensurethattestingpersonnelreceiveadequatetrainingandarecompetenttoperformtheproceduresforwhichtheyareresponsible.9
Certificate Information
NiproDiagnostics,Inc.providesatrainingcertificatefortheuseoftheTRUE2goBloodGlucoseMonitoringSystemforpoint-of-caremulti-patientfacilities.TheTrainingCertificateprovidesarecordthatthepersonlistedontheCertificatehasbeentrainedcorrectlyintheuseoftheTRUE2goSystemandunderstandsallproceduresandlimitationsconcerningtheTRUE2goSystem.
A.CertifiedTrainer
CertifiedTrainersarepersonnelfromthefacilitywhohavereceivedaTrainer’sCertificatefromNiproDiagnostics,Inc.ToobtainaTrainer’sCertificate,thepersonmust:
1.WatchandunderstandtheTRUE2goClinicalTrainingVideo(ifavailable). 2.ReadandbefamiliarwiththeentireQualityAssurance/QualityControlManualandallproduct
InstructionsforUse(TestStrip,GlucoseControlSolution,Owner’sBooklet). 3.CompletetheTrainingChecklistandPostTestincludedinthisManual. 4.SubmitcompletedPostTestto: LTCTrainingCertification Attn.:CustomerCareManager 2400NW55thCt. FortLauderdale,FL33309
NiproDiagnostics,Inc.willreturnaTrainer’sCertificateuponsatisfactorycompletionofthePostTest(100%scorerequired).UponreceivingtheTrainer’sCertificatefromNiproDiagnostics,Inc.,CertifiedTrainersarequalifiedtotrainappropriatepersonnelattheirfacilitytobeApprovedTesters.TrainingChecklistsandCertificatesmustbefiledintheemployee’sfileatthefacility.
• RISKMANAGEMENTANDCHIEFMEDICALOFFICERMUSTBECERTIFIEDACCORDING TO THIS TRAINING CERTIFICATION PROGRAM.
• CERTIFIEDTRAINERSMUSTBERE-CERTIFIEDEVERY12MONTHS.
Nipro Diagnostics will make every effort to contact your facility to inform you of expired training certificate and the need to complete the re-certification process.
TRUE2go® Quality Assurance / Quality Control Manual
43
T2g_QA_ManualTXT_F9NPD21r22.indd 43 12/30/11 10:08 AM
B.ApprovedTesters
ApprovedTestersmustbetrainedbyCertifiedTrainersbeforetheyperformControlTestsorbloodglucosetestingusingtheTRUE2goSystem.TobecomeanApprovedTester:
1.WatchtheTRUE2goClinicalTrainingVideo(ifavailable). 2.SuccessfullycompletetheTrainingChecklistundertheinstructionofaCertifiedTrainer. 3.DemonstratethepropertechniquefortestingwiththeTRUE2goSystemusingtheappropriate
bloodandControlsamples. 4.Identifythefacility’sQualityControlPolicyandProcedures,includingdocumentationofQuality
Control.
Upontheperson’ssatisfactorycompletionoftheabove,theCertifiedTrainerdocumentsthetraining,signstheTrainingChecklistandfilesthecompletedChecklistintheemployee’sfileatthefacility.
APPROVED TESTERS MUST BE RE-TRAINED EVERY 12 MONTHS BY A CERTIFIED TRAINER.
TRUE2go® Quality Assurance / Quality Control Manual
44
T2g_QA_ManualTXT_F9NPD21r22.indd 44 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
45
TRUE2go® Blood Glucose System Training Checklist (Pleaseprint)
Name _______________________________________________________ Date _____/_____/_____
Title _____________________________________________________________________________
Facility __________________________________________________________________________
Confirmed by Certified Trainer (printnameandsign) ____________________________________
1.TheTesterhascompletedthefollowing:
____ViewedtheClinicalTrainingVideo(ifavailable) ____ReadtheOwner’sBooklet ____ReadtheTestStripInstructionsforUse(Insert) ____ReadtheGlucoseControlInstructionsforUse(Insert) ____ReadtheQA/QCManual
2. TheTesterunderstandsthefollowing:
____UseoftheTRUE2goSysteminaclinicalsetting ____CLIAregulationsforpoint-of-carebloodglucosetesting ____Systemspecifications ____Limitationsandcriticalsafetyinformation,includingthattheTRUE2goSystemmustnotbe
usedforcertainpatients(newborns,peritonealdialysispatients,etc.)
3.FamiliarizationwiththecomponentsoftheSystem.
a.Meter
____LocationofserialnumberfortheMeter ____Locationofphonenumberforassistance ____ReviewofMeterbuttonsandfunctions
b.TestStrips
____Identifieslotnumber ____WritesopendateonTestStripviallabel ____UnderstandstheExpirationDates,bothprintedandwritten ____ReviewsproperhandlingofTestStripsincludingrecappingoftheStripvialimmediately
afterremovingTestStrip ____DemonstratesproperinsertionoftheTestStripintotheMeter
c.GlucoseControlSolution
____Identifieslotnumber ____WritesopendateonControlbottlelabel ____UnderstandstheExpirationDates,bothprintedandwritten ____IdentifiesControllevel ____IdentifiesControlranges
T2g_QA_ManualTXT_F9NPD21r22.indd 45 12/30/11 10:08 AM
TRUE2go® Blood Glucose System Training Checklist (Pleaseprint)
Name _______________________________________________________
4. QualityControlTests
____Understandsmanufacturer’sinstructionsforcontroltesting ____Understandsthepurposeoftheautomaticself-checkoftheMeteruponinsertionofTestStrip
intoTestPort ____UnderstandsthepurposeofControlTests,thefrequencyoftesting,andthenumberof
Controllevelstobetested ____Understandsthetestingtemperaturerangeandwhatmayresultiftestingtemperatureisoutof
range ____Identifiescorrect(unopenedvs.opened)ExpirationDatesontheControlbottle ____IdentifiesthecorrectControlrangefortheControllevelandunderstandsthetroubleshooting
iftheControlTestresultisnotwithintheacceptablerange ____DemonstratestheprocedureusingtheGlucoseControlSolution ____RecordstheControlTestresultontheTRUE2goQualityControlLog
5. BloodCollection
____Understandsthepropertechniqueofcapillarybloodcollectionforbothfingerandforearmsamples
____Understandswhenfingershouldbeusedinsteadofforearm ____Demonstratestheabilitytoobtainasufficientamountofbloodfortestingfrombothafinger
tipandforearm ____Understandsfacility’sprocedureonobtainingvenousbloodsamplesandthecorrecttubestouse
6. DemonstrationofBloodGlucoseTesting
____DemonstratesproperbloodglucosetestingprocedurefortheTRUE2goSystem ____UnderstandstheproperbloodapplicationtotheSampleTipandthesignificanceofthe
symbolsintheDisplay
7. PatientBloodGlucoseTestResults
____Demonstratestheproperdocumentationoftestresults ____Understandsthetroubleshootingiftestresultsarenotwithinthepatienttargetrange(e.g.,
performQualityControlTests,repeattest,possibletherapychangeafterconsultationwithDoctororDiabetesHealthcareProfessional,etc.)
____UnderstandsthatuseofMemoryfeaturemaynotbeappropriateformulti-patientfacilities. ____Properdisposalofbiohazardousmaterialsperfacilitypolicyandprocedures
8. Care,Cleaning/DisinfectionandStorageofSystem
____Understandsanycleaning/disinfectingproceduresforInfectionControl ____Demonstratesbatteryreplacement ____UnderstandsproperstorageofMeter,TestStrips,andGlucoseControlSolution
TRUE2go® Quality Assurance / Quality Control Manual
46
T2g_QA_ManualTXT_F9NPD21r22.indd 46 12/30/11 10:08 AM
TRUE2go® Blood Glucose System Certified Trainer Post Test (Pleaseprint)
Name _______________________________________________________ Date _____/_____/_____
Title _________________________________________Facility _____________________________
DoesthefacilitycorrespondingtothisTrainingCertificationprovideanyofthefollowingpatientservices? __________Yes __________No
- Peritonealdialysiswithsolutionscontainingicodextrin(e.g.Extraneal,Icodial)thatismetabolizedtomaltose,
- Injectionsorinfusionsofsolutionscontaininggalactoseormaltose,includingsomehumanimmunoglobulinpreparations(e.g.Octagam),
- Xyloseabsorptiontesting,- Intervenoussolutionscontainingmaltoseasasubstituteforglucoseorasameansforpatient
hydration,- Drugs,includinginvestigationaldrugsandthosemadebycompoundingpharmacies,which
containormetabolizemaltose,galactose,orxylose.
Address __________________________________________________________________________
Phone/Fax________________________________________________________________________
E-mail Address* ___________________________________________________________________*Forproductupdatesandrecertificationnotices.Notforpromotionalpurposes.
True or False
1.AllHealthcareProfessionalsperformingbloodglucosemonitoringusingtheTRUE2goSystemshouldcompletethetrainingprogram.
__________True __________False
2.TheTRUE2goSystemcanbeusedonnewborns.
__________True __________False
3.Apatientreceivingperitonealdialysiswithicodextrin(ExtranealorIcodial)orsolutionscontainingmaltoseormetabolizingtomaltose,orgalactose(suchasOctagam)canbetestedusingtheTRUE2goSystem.
__________True __________False
4.TheTRUE2goMetermaybeusedwithoutattachmenttotheTestStripvial.
__________True __________False
TRUE2go® Quality Assurance / Quality Control Manual
47
T2g_QA_ManualTXT_F9NPD21r22.indd 47 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
48
TRUE2go® Blood Glucose System Certified Trainer Post Test (Pleaseprint)
Name _______________________________________________________
5.QualityControlTestingshouldbeperformedperyourfacility’spoliciesandprocedures.
__________True __________False
6.AnycontrolsolutioncanbeusedwiththeTRUE2goSystem.
__________True __________False
7.Criticallyillpatients(shock,hyperglycemic-hyperosmolarstate,withorwithoutketosis)shouldbe testedwiththeTRUE2goSystem.
__________True __________False
8.IftheMeterbecomessoiled,wipeitoffwithIsopropylalcohol(70%)wipes,PDISuperSani-clothwipesorViraguardwipes.
__________True __________False
9.ThebatteryshouldbereplacedwithanAAAalkalinebattery.
__________True __________False
Multiple Choice (choose only one answer for each question)
1.TrainingontheuseoftheTRUE2goSystemconsistsofreviewingthefollowing:
a)TheClinicalTrainingVideo(ifavailable) b)TheQA/QCManual c)TheOwner’sBooklet d)TestStripInstructionsforUse e)ControlSolutionInstructionsforUse f)Alloftheabove
2.Ifapoint-of-carebloodglucosetestisorderedonapatient,thetestermust:
a)Identifytreatment(s)patientmaybeonorstarting b)Identifydrugtherapy(ies)patientmaybeonorstarting c)Identifyanduseappropriatepoint-of-carebloodglucosetestingsystem d)Alloftheabove
T2g_QA_ManualTXT_F9NPD21r22.indd 48 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
49
TRUE2go® Blood Glucose System Certified Trainer Post Test (Pleaseprint)
Name _______________________________________________________
3.TheTRUE2goSystemutilizesthefollowingenzymetotestforglucose:
a)Glucoseoxidase(GO) b)GDH-PQQ c)GDH-NAD d)GEH-PDQ
4.TheTRUE2goSystemmustnotbeusedforthefollowingpatientconditions:
a)Peritonealdialysispatientsreceivingdialysissolutionscontainingicodextrin(e.g. Extraneal®,Icodial®)thatismetabolizedtomaltoseb)Injectionorinfusionofsolutionscontaininggalactoseormaltose,includingsome humanimmunoglobulinpreparations(e.g.Octagam®)c) Patientsundergoingxyloseabsorptiontestingd)Patientsreceivingintravenoussolutionscontainingmaltoseasasubstituteforglucoseoras ameansforpatienthydratione)Anydrugs,includinganyinvestigationaldrugsandthosemadebycompoundingpharmacies. whichcontainormetabolizetomaltose,galactose,orxylosef) Alloftheabove
5.UsingtheTRUE2goSystemontheabovepatientsmaycause:
a)Falselowglucoseresults b)Metertomalfunction c)Falsehighglucoseresults d)Controlsolutiontoreadasblood e)Inappropriatetreatmentthatmayresultindeath f)aandd g)cande h)bande
6.Thefollowingsample(s)is/areappropriatefortestingontheTRUE2goSystem:
a)Capillarywholebloodfromfingertiporforearm b)Venouswholebloodcollectedinaredtoptube c)Plasma d)Urine e)Venouswholebloodcollectedinapurpletoporgreentoptube f)aandc g)bandd h)aande
T2g_QA_ManualTXT_F9NPD21r22.indd 49 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
50
TRUE2go® Blood Glucose System Certified Trainer Post Test (Pleaseprint)
Name _______________________________________________________
7.Thephonenumberforassistanceislocated:
a)OntheOwner’sBookletcover b)OnthecoveroftheQA/QCManual c)OnthebackMeterlabel d)OntheTestStripInstructionsforUse e)Alloftheabove
8.ThefollowingtestsareusedforQualityControloftheTRUE2go:
a)OnelevelofGlucoseControlandapatientsample b)OnelevelofGlucoseControl c)AlowlevelofGlucoseControlandahighlevelofGlucoseControl d)Meterautomaticself-testandaminimumof2levelsofGlucoseControl
9.TheGlucoseControlopenbottleexpirationdateis:
a)Oneweekafteropening b)120daysafteropening c)3monthsafteropening d)Thedatepre-printedonthebottle
10.IftheControlTestresultisoutofrange,itmaybebecause:
a)TheControlhasexpired b)TheTestStriphasexpiredorthevialwasnotclosed c)ThecapwasleftofftheControlbottle d)TheopendatewrittenontheControlbottleorTestStripvialhaspassed e)Alloftheabove
11.Forearmtestingmaynotbeappropriateinthefollowingsituations:
a)Within2hoursofexercise b)Ifthepatient’sglucoseresultoftenfluctuates c)Ifthepatientisunderstress d)Alloftheabove
12.TRUEtestTestStripsopenvialexpirationdateis:
a)18months b)12months c)6months d)4months
T2g_QA_ManualTXT_F9NPD21r22.indd 50 12/30/11 10:08 AM
13.Retrainingofallpersonnelmustbeperformedwithin
a)6months b)12months c)8months d)30days
14.IfafterinsertingtheTestStripintotheTestPort,theMeterdoesnotturnon,thereasoncouldbe
a)TheTestStripwasinsertedupsidedown b)TheTestStripwasnotfullyinserted c)Thebatteryisdead d)Alloftheabove
For Nipro Diagnostics, Inc. Use Only
Score _______________________________________________________
Reviewed by _________________________________________________ Date _____/_____/_____ Printname
____________________________________________________________ Signname
CertificateIssued: ____________Yes____________NoDate _____/_____/_____
TRUE2go® Quality Assurance / Quality Control Manual
51
T2g_QA_ManualTXT_F9NPD21r22.indd 51 12/30/11 10:08 AM
TRUE2go® Quality Assurance / Quality Control Manual
52
T2g_QA_ManualTXT_F9NPD21r22.indd 52 12/30/11 10:08 AM
54
QU
ALI
TY C
ON
TRO
L R
ECO
RD
Met
er S
eria
l Num
ber _
____
____
____
____
(7-d
igit
num
bero
nM
eter
labe
lbelow
theba
rcod
e)*N
ote
any
prob
lem
s in
Trou
bles
hoot
ing
sect
ion
belo
w.
Test
Str
ips
Glu
cose
Con
trol
- Le
vel _
____
____
_G
luco
se C
ontr
ol -
Leve
l ___
____
___
Dat
eTi
me
LOT
Dat
e O
pene
dD
ate
Ope
ned
Acc
epta
ble
Ran
geD
ate
Ope
ned
Acc
epta
ble
Ran
geLO
TR
esul
tLO
TEX
PEX
PEX
PR
esul
tIn
itial
s*
*TR
OU
BLES
HO
OTI
NG
Dat
ePr
oble
mA
ctio
nIn
itial
s
On
TRUEt
estT
est
Strip
vialla
bel,
writed
atevial
open
ed.D
iscar
dvialif
eith
er4m
onth
safte
rop
enin
gor
afte
rEX
Pda
tep
rint
ed
onth
evialla
belh
as
passed
.
On
TRUEt
est
Con
trol
bot
tlela
bel,
writ
eda
teb
ottle
op
ened
.Disc
ard
bottl
eif
eith
er
3m
onth
safte
rop
enin
gor
afte
rEX
Pda
tep
rinted
onth
ebo
ttlelabe
lha
spas
sed.
On
TRUEt
est
Con
trol
bot
tlela
bel,
writ
eda
teb
ottle
op
ened
.Disc
ard
bottl
eif
eith
er
3m
onth
safte
rop
enin
gor
afte
rEX
Pda
tep
rinted
onth
ebo
ttlelabe
lha
spas
sed.
Prin
ted
on
vial
labe
lof
Te
st
Strips
be
ing
used
.
Prin
ted
on
vial
labe
lof
Te
st
Strips
be
ing
used
.
T2g_QA_ManualTXT_F9NPD21r22.indd 54 12/30/11 10:08 AM
55
QU
ALI
TY C
ON
TRO
L R
ECO
RD
Met
er S
eria
l Num
ber _
____
____
____
____
(7-d
igit
num
bero
nM
eter
labe
lbelow
theba
rcod
e)*N
ote
any
prob
lem
s in
Trou
bles
hoot
ing
sect
ion
belo
w.
Test
Str
ips
Glu
cose
Con
trol
- Le
vel _
____
____
_G
luco
se C
ontr
ol -
Leve
l ___
____
___
Dat
eTi
me
LOT
Dat
e O
pene
dD
ate
Ope
ned
Acc
epta
ble
Ran
geD
ate
Ope
ned
Acc
epta
ble
Ran
geLO
TR
esul
tLO
TEX
PEX
PEX
PR
esul
tIn
itial
s*
*TR
OU
BLES
HO
OTI
NG
Dat
ePr
oble
mA
ctio
nIn
itial
s
T2g_QA_ManualTXT_F9NPD21r22.indd 55 12/30/11 10:08 AM
At-Risk Patient Identification Notice(For patient bedside, with patient chart and in applicable treatment areas)
WARNING!Do not use TRUE2go System
for Blood Glucose Testing!_______ Patient on peritoneal dialysis
_______ Patient receiving solutions containing galactose or maltose, including some human immunoglobulin preparations
_______ Patient undergoing xylose absorption testing
_______ Patient receiving IV solution containing maltose
_______ Patient receiving drug therapies that contain or metabolize to maltose, galactose, or xylose
WARNING!
TRUE2go® Quality Assurance / Quality Control Manual
56
T2g_QA_ManualTXT_F9NPD21r22.indd 56 12/30/11 10:08 AM
TRUE2go Limited Lifetime Warranty
NiproDiagnostics,Inc.providesthefollowingWarrantytotheoriginalpurchaseroftheTRUE2goBloodGlucoseMeter:
1)NiproDiagnostics,IncwarrantsthisMetertobefreeofdefectsinmaterialsandworkmanshipatthetimeofpurchase.IftheMeteriseverinoperative,NiproDiagnostics,Inc.willreplacetheMeterwithanequivalentMeter,atitsoption,atnocosttothepurchaser.FailureoftheMeterduetoabuseorusenotinaccordancewiththeinstructionsforuseisnotcoveredbythisWarranty.
2)ThisWarrantydoesnotincludethebatterysuppliedwiththeMeter.3)DonottaketheMeterapart.ThisactionwillvoidtheWarrantyandcausethe
Metertodisplayfalseresults.4)ThedurationofanyimpliedWarranty,includinganyimpliedWarrantyof
merchantabilityorfitnessforaparticularpurposeshallbelimitedtothelifetimeinusewiththeoriginaluserinaccordancewithanystatelawtothecontrary.
5)NiproDiagnostics,Inc.disclaimsliabilityforincidentalorconsequentialdamagesforbreachofanyexpressedorimpliedWarranty,includinganyimpliedWarrantyofmerchantabilityorfitnessforaparticularusewithrespecttotheMeter.Somestatesdonotallowtheexclusionorlimitationofincidentalorconsequentialdamages,sotheabovelimitationsorexclusionmaynotapply.
6)ThisWarrantygivestheuserspecificlegalrights,andtheusermayalsohaveotherrightswhichvarystatetostate.
YourNiproDiagnostics,Inc.CustomerCareRepresentativewillbeabletoprovidedetailedinformationregardingproceduresforreturningyourMeter,ifnecessary.
TRUE2go® Quality Assurance / Quality Control Manual
58
T2g_QA_ManualTXT_F9NPD21r22.indd 58 12/30/11 10:08 AM
References
1. FDAPublicHealthNotification:Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting Blood Borne Pathogens: Initial Communication (2010)http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices.
2. CDCClinicalReminder:Use of Fingerstick Devices on More than one Person Poses Risk for Transmitting Bloodborne Pathogens (2010)http://www.cdc.gov/injectionsafety/Fingerstick-DevicesBGM.html.
3. U.S.FoodandDrugAdministration,CenterforBiologicsEvaluationandResearch.Important Safety Information on Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/ParenteralGalactose/Oral Xylose - Containing Products.[ElectronicVersion].RetrievedJune30,2009.www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.htm.
4. U.S.FoodandDrugAdministration.Blood Glucose Meters - Getting the Most Out of Your Meter.[ElectronicVersion].RetrievedJune16,2009:www.fda.gov/MedicalDevices/Safety/AlertsandNotices/TipsandArticlesonDeviceSafety/ucm109371.htm.
5. Dataonfile.
6. Larsson-CohnU:Difference between capillary and venous blood glucose during oral glucose tolerance tests.ScandJClinLabInvest36:805-808,1976.
7. Atkins,S.H.,Dasmahapatra,A.,Jaker,M.A.,Chorost,M.I.,Redd,S.,Fingerstick Glucose Determination in Shock.AnnalsofInternalMedicine,114:1020-1024,1991.
8. JoslinDiabetesCenter.GoalsforBloodGlucoseControl[ElectronicVersion].RetrievedSeptember28,2010.fromwww.joslin.org/info/goals_for_blood_glucose_control.htm.
9. Good Laboratory Practices for Waived Testing Sites.[ElectronicVersion].RetrievedJuly14,2008:www.cdc.gov/mmwr/preview/mmwrhtml/rr5413a1.htm.
TRUE2go® Quality Assurance / Quality Control Manual
60F9NPD21Rev.22
T2g_QA_ManualTXT_F9NPD21r22.indd 60 12/30/11 10:08 AM